Safety of drugs during previous and current coronavirus pandemics: Lessons for IBD

Journal of Crohn's & Colitis
Shaji SebastianLaurent Peyrin-Biroulet

Abstract

The Coronavirus 2019 (COVID-19) pandemic has posed challenges in the routine care of patients with inflammatory bowel disease. One of the key challenges needing addressing is the quantification of the risks of immunosuppressive and biologic therapies in IBD patients during the pandemic. The similarities and differences between the previous coronavirus outbreaks and the pathobiology of the infections can give useful information in understanding the risks, and perhaps potential beneficial aspects of drugs used in IBD. Although clinical, immunological and pharmacological data from the experience with the previous coronavirus outbreaks cannot be automatically translated to predict the safety of IBD therapies during COVID-19 pandemic, the signals so far from these outbreaks on IBD patients who are on immunomodulators and biologics are reassuring to patients and clinicians alike.

References

Sep 6, 2001·European Journal of Immunology·T HussellP J Openshaw
Dec 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Heike SchäckeKhusru Asadullah
Jan 27, 2004·Current Medical Research and Opinion·Edward Tobinick
Mar 20, 2004·Clinical and Experimental Immunology·C K WongJ J Y Sung
Oct 21, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Nelson LeeY M Dennis Lo
Nov 24, 2004·American Journal of Respiratory and Critical Care Medicine·Marco ConfalonieriG Umberto Meduri
Dec 3, 2005·Nature Reviews. Immunology·Stanley Perlman, Ajai A Dandekar
Mar 18, 2006·The Journal of Infection·Loretta Yin-Chun YamUNKNOWN Hong Kong Hospital Authority SARS Collaborative Group (HASCOG)
May 13, 2006·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Tracey BaasMichael G Katze
Sep 14, 2006·PLoS Medicine·Lauren J StockmanPaul Garner
May 21, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shiori HagaYukihito Ishizaka
May 15, 2010·Veterinary Immunology and Immunopathology·Kalina AtanasovaKristien Van Reeth
Apr 8, 2011·American Journal of Respiratory and Critical Care Medicine·Christian Brun-BuissonUNKNOWN REVA-SRLF A/H1N1v 2009 Registry Group
Jul 15, 2011·The Journal of General Virology·Adriaan H de WildeMartijn J van Hemert
Feb 22, 2012·Virus Research·Javier Carbajo-LozoyaAlbrecht von Brunn
Feb 12, 2013·The Journal of Infection·Clark D Russell, Juergen Haas
Nov 5, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Matthew J MemoliJeffery K Taubenberger
Feb 20, 2014·International Journal of Clinical Practice·S LvR Wang
Mar 13, 2014·Journal of Crohn's & Colitis·J F RahierUNKNOWN European Crohn's and Colitis Organisation (ECCO)
May 16, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mohammad Mousa Al-AbdallatUNKNOWN Jordan MERS-CoV Investigation Team
Apr 24, 2015·The Journal of Infectious Diseases·Nelson LeePaul K S Chan
Jun 3, 2016·Journal of Crohn's & Colitis·Tim WyantBrihad Abhyankar
Dec 10, 2016·Translational Research : the Journal of Laboratory and Clinical Medicine·Patrick P C BoorJaap Kwekkeboom
Jan 7, 2017·BMC Infectious Diseases·Fadilah Sfouq AleanizyRania Ali El Hadi Mohamed
Apr 28, 2017·Alimentary Pharmacology & Therapeutics·W A ByeS P L Travis
May 4, 2017·Influenza and Other Respiratory Viruses·Hui LiUNKNOWN National Influenza A(H1N1)pdm09 Clinical Investigation Group of China
May 27, 2017·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Si-Ho KimKyong Ran Peck
Nov 22, 2017·American Journal of Respiratory and Critical Care Medicine·Yaseen M ArabiUNKNOWN Saudi Critical Care Trial Group
Feb 28, 2018·Frontiers in Immunology·Joseph PrescottVincent Jacobus Munster

❮ Previous
Next ❯

Citations

Jul 29, 2020·Clinical Medicine : Journal of the Royal College of Physicians of London·Haidee A GonzalezShaji Sebastian
Aug 28, 2020·Alimentary Pharmacology & Therapeutics·Carlos TaxoneraCristina Alba
Mar 30, 2021·World Journal of Gastroenterology : WJG·Júlio Maria Fonseca ChebliRogério Serafim Parra
May 21, 2021·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Alex BarnesRéme Mountifield
Jul 24, 2021·Molecular Biology Reports·K A DvornikovaA Lerner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.